May 7 (Reuters) - Anglo-Swedish drugmaker AstraZeneca (AZN.L), opens new tab is withdrawing its COVID-19 vaccine worldwide, the Telegraph reported on Tuesday.
The vaccine can no longer be used in the European Union after the company voluntarily withdrew its "marketing authorisation", the report stated.
The application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the report, which added that similar applications would be made in the UK and other countries that had approved the vaccine, known as Vaxzevria, in the coming months.
Vaxzevria is under global scrutiny due to a rare side effect causing blood clots and low blood platelet counts.